Company / Gross Margin
Bio-Rad Laboratories Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
51.9%
FY2025
5-year range
51.9% / 56.0%
FY2021-FY2025
Trend
-3.5%
vs FY2024
Sector context
#59 of 96
Health Care
What the data says
At 51.9%, Bio-Rad Laboratories's gross margin ranks #59 of 96 in the Health Care sector. Gross Margin remained relatively stable over the past 10 years, with values between 51.9% and 56.0%.
Based on SEC 10-K filings.
51.9% in FY2025 with a 5-year CAGR of -1.6%.
Declined from 53.4% to 51.9% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -4.1pp
- 5-Year Change
- -1.6pp
- 10-Year Change
- -
Sector benchmark
#59 of 96 in Health CareTop 61% of 96This company 51.9% Sector average 53.6%
▼
-3.2% below sector average
Key checks
Key Insights
- In FY2025, gross margin decreased 3.5% year-over-year.
- Currently 1.7pp below the Health Care sector average.
- Peak gross margin was recorded in FY2021.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 51.9% | -3.5% |
| FY2024 | 53.7% | +0.6% |
| FY2023 | 53.4% | -4.5% |
| FY2022 | 55.9% | -0.2% |
| FY2021 | 56.0% | +4.9% |
| FY2020 | 53.4% | -1.7% |
| FY2019 | 54.4% | -1.2% |
| FY2018 | 55.0% | -0.9% |
| FY2017 | 55.5% | +2.5% |
| FY2016 | 54.2% | -2.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026